Ketoderm (Ketoconazole)

Ketoconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of the fungal cell membrane. Disruption of ergosterol production compromises membrane integrity, leading to fungal cell death and clearance of the infection.

The dosage of Ketoderm is determined by the prescribing healthcare professional based on the specific infection, its severity, and the patient’s condition. The prescriber will provide instructions on the amount to apply, frequency, and duration of treatment.

Safety data for topical ketoconazole in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing Ketoderm to pregnant or nursing individuals. Patients should discuss their situation with a qualified professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Ketoderm. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoderm’s active ingredient, ketoconazole, belongs to the azole class and offers broad‑spectrum activity against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, ketoconazole may be preferred for infections involving Malassezia species, like seborrheic dermatitis, while terbinafine is often chosen for nail infections.

Ketoderm should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from excessive moisture, direct sunlight, and extreme temperatures to maintain its stability and effectiveness.

Ketoderm is applied topically to the affected skin area. Clean and dry the skin before use, then spread a thin layer of the product over the lesion as directed by the prescriber, typically once or twice daily for the prescribed duration.

Serious risks, though rare, include severe allergic reactions such as angioedema or anaphylaxis, extensive skin rash, Stevens‑Johnson syndrome, and, in exceptional cases, systemic toxicity like hepatotoxicity if significant absorption occurs. Immediate medical attention is required if these symptoms develop.

Ketoderm should not be used by individuals with known hypersensitivity to ketoconazole or any component of the formulation. It is also contraindicated on severely damaged, inflamed, or broken skin, and should be avoided in patients with a history of severe allergic skin reactions.